Prescription Drug Recall: Eligard Leuprolide Contains Higher Than Expected Levels
Tolmar, Inc. is recalling Eligard (leuprolide acetate) 7.5 mg monthly injectable suspension nationwide because the constituted product contains higher than expected levels of the active ingredient. The affected lot is 13635A1 with expiration date July 31, 2024.
- Product
- ELIGARD — ELIGARD (LEUPROLIDE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide